Trump administration funding cuts and dismantling of USAID force the focus to shift from elimination back to treatment.

USAID has been present in Uganda for over sixty years. It has funded development in agriculture, education and research in ...

A new twice-yearly antiviral injection that can prevent HIV is likely to be approved soon in Australia. Making it affordable ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...

The approval of Yeztugo is a momentous step in improving PrEP options available for people vulnerable to contracting ...

Many fell under the President’s Emergency Plan for Aids Relief (Pepfar) programme, which has been the backbone of global ...

The drug, in June, received FDA approval as the first twice-yearly pre-exposure prophylaxis (PrEP) option to reduce the risk ...

South Africa’s HIV programme is the biggest in the world, but now it’s been cut thin, with the loss of billions in US funding ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

The Makerere University–Johns Hopkins University Research Collaboration has announced ongoing studies aimed at extending the ...

Drugs to prevent HIV transmission, known as pre-exposure prophylaxis or PrEP, have existed for more than a decade. But ...